tirzepatide review article PDF) and Cardiovascular Outcomes: A Narrative of Mechanisms, Efficacy and Implications for Heart Failure Management F.D.A. Approves New Obesity Drug

This would be in line with preclinical observations that incretin receptor expression is down-regulated by exposure to high glucose, and improves once normoglycaemia is restored (48), and that dys-regulation of glycaemic control in otherwise healthy humans leads to impaired incretin actions (49)

Semaglutide is widely used in people with type 2 diabetes

As of 2025, retatrutide has not received MHRA or EMA approval and is not available via NHS prescription or licensed private clinics in the UK

INDIANAPOLIS A clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide a medication typically prescribed to Type 2 diabetes patients improved blood sugar levels and weight loss for adult Type 1 diabetes patients who use automated insulin delivery systems and have a body mass index of 30 or higher

It should not be used in patients with type 1 diabetes or in patients with diabetic ketoacidosis

Functional studies revealed that activation of GLP-1R in the PVN reduces food intake (Larsen et al., 1997